Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 30, 2014, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $105.05 to $21,917,679.52.

Highlighted Stocks Traded by Insiders:

Illinois Tool Works (ITW) - FREE Research Report

Mccormack Robert C, who is Director at Illinois Tool Works, sold 28,700 shares at $84.55 on April 30, 2014. Following this transaction, the Director owned 3.9 million shares meaning that the stake was reduced by 0.72% with the 28,700-share transaction.

The shares most recently traded at $85.62, up $1.07, or 1.25% since the insider transaction. Historical insider transactions for Illinois Tool Works go as follows:

  • 4-Week # shares sold: 12,400
  • 12-Week # shares bought: 7,000
  • 12-Week # shares sold: 12,400
  • 24-Week # shares bought: 7,000
  • 24-Week # shares sold: 12,400

The average volume for Illinois Tool Works has been 2.5 million shares per day over the past 30 days. Illinois Tool Works has a market cap of $35.6 billion and is part of the industrial goods sector and industrial industry. Shares are up 1.37% year-to-date as of the close of trading on Wednesday.

Illinois Tool Works Inc. produces and sells engineered fasteners and components, equipment and consumable systems, and specialty products. The stock currently has a dividend yield of 2.05%. The company has a P/E ratio of 22.5. Currently, there are 9 analysts who rate Illinois Tool Works a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ITW - FREE

TheStreet Quant Ratings rates Illinois Tool Works as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Illinois Tool Works Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Clearwater Paper (CLW) - FREE Research Report

Johansen Danny G., who is Sr. V.P., Pres. P&P at Clearwater Paper, bought 500 shares at $59.83 on April 30, 2014. Following this transaction, the Sr. V.P., Pres. P&P owned 15,469 shares meaning that the stake was reduced by 3.34% with the 500-share transaction.

The shares most recently traded at $61.33, up $1.50, or 2.45% since the insider transaction. Historical insider transactions for Clearwater Paper go as follows:

  • 24-Week # shares bought: 4,000

The average volume for Clearwater Paper has been 185,300 shares per day over the past 30 days. Clearwater Paper has a market cap of $1.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 16.27% year-to-date as of the close of trading on Wednesday.

Clearwater Paper Corporation manufactures and sells private label tissue and paperboard products in the United States and internationally. The company operates through two segments, Consumer Products, and Pulp and Paperboard. The company has a P/E ratio of 12.9. Currently, there is 1 analyst who rates Clearwater Paper a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLW - FREE

TheStreet Quant Ratings rates Clearwater Paper as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, solid stock price performance and compelling growth in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Clearwater Paper Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Health Care REIT (HCN) - FREE Research Report

Ibele Erin C, who is Sr. VP-Admin. & Corp. Secy. at Health Care REIT, sold 900 shares at $63.00 on April 30, 2014. Following this transaction, the Sr. VP-Admin. & Corp. Secy. owned 56,991 shares meaning that the stake was reduced by 1.55% with the 900-share transaction.

The shares most recently traded at $62.60, down $0.40, or 0.64% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 4-Week # shares sold: 400
  • 12-Week # shares sold: 400
  • 24-Week # shares sold: 400

The average volume for Health Care REIT has been 1.7 million shares per day over the past 30 days. Health Care REIT has a market cap of $18.3 billion and is part of the financial sector and real estate industry. Shares are up 17.77% year-to-date as of the close of trading on Wednesday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 5.45%. The company has a P/E ratio of 583.9. Currently, there are 6 analysts who rate Health Care REIT a buy, 2 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null